| 发明名称 |
Sustained release dosage forms for a JAK1 inhibitor |
| 摘要 |
This invention relates to sustained release dosage forms comprising {1-{1-[3-fluoro-2-(trifluoromethyl)isonicotinoyl]piperidin-4-yl}-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl}acetonitrile, or a pharmaceutically acceptable salt thereof, and doses and methods related thereto. |
| 申请公布号 |
AU2014305989(A1) |
申请公布日期 |
2016.03.10 |
| 申请号 |
AU20140305989 |
申请日期 |
2014.08.06 |
| 申请人 |
INCYTE CORPORATION |
发明人 |
YELESWARAM, KRISHNASWAMY;PARIKH, BHAVNISH;MODI, DILIP P.;SHETH, TRUPTI |
| 分类号 |
A61K9/20;A61K31/4045 |
主分类号 |
A61K9/20 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
